Innovac Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-06-2024
- Paid Up Capital ₹ 0.10 M
as on 24-06-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 119.78%
(FY 2021)
- Profit 89.77%
(FY 2021)
- Ebitda 125.79%
(FY 2021)
- Net Worth 53.16%
(FY 2021)
- Total Assets 107.78%
(FY 2021)
About Innovac Bioscience
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mayank Patel, Raxitkumar Patel, and Sauminkumar Patel serve as directors at the Company.
- CIN/LLPIN
U01403GJ2015PTC084621
- Company No.
084621
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Innovac Bioscience Private Limited offer?
Innovac Bioscience Private Limited offers a wide range of products and services, including Mosquito & Insect Repellent, Insect Trap, Insecticides and Pesticides, Acaricide, Fertilizers and Soil Additives, Fertilizer, Pheromone Trap, Insecticides, Organic Pesticides, Azadirachtin.
Who are the key members and board of directors at Innovac Bioscience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sauminkumar Patel  | Director | 29-Sep-2015 | Current |
| Mayank Patel | Director | 29-Sep-2015 | Current |
| Raxitkumar Patel | Director | 29-Sep-2015 | Current |
Financial Performance and Corporate Structure Insights of Innovac Bioscience.
Innovac Bioscience Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 119.78% increase. The company also saw a substantial improvement in profitability, with a 89.77% increase in profit. The company's net worth Soared by an impressive increase of 53.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovac Bioscience?
In 2021, Innovac Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innovac Bioscience?
Unlock and access historical data on people associated with Innovac Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovac Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovac Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
